These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34273795)

  • 1. Factors Associated with Non-Operative Management of Resectable Adrenocortical Carcinoma.
    Tseng J; DiPeri T; Chen Y; Ben-Shlomo A; Shouhed D; Phillips EH; Burch M; Jain M
    J Surg Res; 2021 Nov; 267():651-659. PubMed ID: 34273795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operative approach and case volume are associated with negative resection margins for adrenocortical carcinoma.
    Tseng J; Diperi T; Gonsalves N; Chen Y; Ben-Shlomo A; Shouhed D; Phillips E; Burch M; Jain M
    Surg Endosc; 2022 Dec; 36(12):9288-9296. PubMed ID: 35246741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical carcinoma: effect of hospital volume on patient outcome.
    Lombardi CP; Raffaelli M; Boniardi M; De Toma G; Marzano LA; Miccoli P; Minni F; Morino M; Pelizzo MR; Pietrabissa A; Renda A; Valeri A; De Crea C; Bellantone R
    Langenbecks Arch Surg; 2012 Feb; 397(2):201-7. PubMed ID: 22069043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operative intervention for recurrent adrenocortical cancer.
    Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
    Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally Invasive Surgery for Resectable Adrenocortical Carcinoma: A Nationwide Analysis.
    Delman AM; Turner KM; Griffith A; Schepers E; Ammann AM; Holm TM
    J Surg Res; 2022 Nov; 279():200-207. PubMed ID: 35780533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.
    Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M
    J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis.
    Naffouje SA; Sabesan A; Hallanger-Johnson J; Kirtane K; Gonzalez RJ; Mullinax J
    J Surg Oncol; 2021 Dec; 124(8):1261-1271. PubMed ID: 34424540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival characteristics of localized pediatric adrenocortical carcinoma managed with adenectomy: A national cancer center database analysis.
    Evanoff JD; Patel SG; Hickey KJ; Rensing AJ
    J Pediatr Urol; 2021 Oct; 17(5):735.e1-735.e6. PubMed ID: 34210620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment differences at high volume centers and low volume centers in non-metastatic and metastatic adrenocortical carcinoma.
    MacKinney EC; Holoubek SA; Khokar AM; Kuchta KM; Moo-Young TA; Prinz RA; Winchester DJ
    Am J Surg; 2022 Mar; 223(3):582-586. PubMed ID: 35151433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
    Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
    Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.
    Miller BS; Gauger PG; Hammer GD; Giordano TJ; Doherty GM
    Langenbecks Arch Surg; 2010 Sep; 395(7):955-61. PubMed ID: 20694732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
    Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
    Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical carcinoma surgery-surgical extent and approach.
    Vanbrugghe C; Lowery AJ; Golffier C; Taieb D; Sebag F
    Langenbecks Arch Surg; 2016 Nov; 401(7):991-997. PubMed ID: 27412357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in access to care and outcomes in patients with adrenocortical carcinoma.
    Hammad AY; Yen TWF; Carr AA; Evans DB; Wang TS
    J Surg Res; 2017 Jun; 213():138-146. PubMed ID: 28601306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data.
    Kerkhofs TM; Verhoeven RH; Bonjer HJ; van Dijkum EJ; Vriens MR; De Vries J; Van Eijck CH; Bonsing BA; Van de Poll-Franse LV; Haak HR;
    Eur J Endocrinol; 2013 Jul; 169(1):83-9. PubMed ID: 23641018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.
    Liang J; Liu Z; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Wei X; Lu Y; Zhu Y
    Endocrine; 2020 Feb; 67(2):449-456. PubMed ID: 31786772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management and clinical prognosis of adrenocortical carcinoma.
    Dong D; Li H; Yan W; Ji Z; Mao Q
    Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature.
    Mpaili E; Moris D; Tsilimigras DI; Oikonomou D; Pawlik TM; Schizas D; Papalampros A; Felekouras E; Dimitroulis D
    J Laparoendosc Adv Surg Tech A; 2018 Apr; 28(4):408-414. PubMed ID: 29319399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group.
    Poorman CE; Ethun CG; Postlewait LM; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solórzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
    Ann Surg Oncol; 2018 Feb; 25(2):520-527. PubMed ID: 29164414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate Practice Patterns and Survival Outcomes: The Impact of Centralization of Cancer Care for Adrenocortical Carcinoma in the United States.
    Stone BV; Tallman JE; Moses KA
    J Urol; 2021 Oct; 206(4):866-872. PubMed ID: 34032493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.